tiprankstipranks
Pharma Mar SA (ES:PHM)
:PHM
Spanish Market

Pharma Mar SA (PHM) Stock Forecast & Price Target

Compare
11 Followers
See the Price Targets and Ratings of:

PHM Financial Forecast

PHM Earnings Forecast

Next quarter’s earnings estimate for PHM is -€0.17 with a range of -€0.17 to -€0.17. The previous quarter’s EPS was €0.20. PHM beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.13% of the time in the same period. In the last calendar year PHM has Outperformed its overall industry.
Next quarter’s earnings estimate for PHM is -€0.17 with a range of -€0.17 to -€0.17. The previous quarter’s EPS was €0.20. PHM beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.13% of the time in the same period. In the last calendar year PHM has Outperformed its overall industry.

PHM Sales Forecast

Next quarter’s sales forecast for PHM is €42.90M with a range of €42.30M to €43.50M. The previous quarter’s sales results were €45.66M. PHM beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 46.63% of the time in the same period. In the last calendar year PHM has Outperformed its overall industry.
Next quarter’s sales forecast for PHM is €42.90M with a range of €42.30M to €43.50M. The previous quarter’s sales results were €45.66M. PHM beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 46.63% of the time in the same period. In the last calendar year PHM has Outperformed its overall industry.

Detailed List of Analyst Forecasts​

Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Chardan Capital
€60
Buy
-39.67%
Downside
Reiterated
10/15/24
Oddo BHF Analyst forecast on ES:PHM
Juan Ros Padilla
Not Ranked
Oddo BHF
€48
Hold
-51.73%
Downside
Downgraded
10/07/24
Pharma Mar downgraded to Neutral from Outperform at Oddo BHFPharma Mar downgraded to Neutral from Outperform at Oddo BHF
Needham
€70
Buy
-29.61%
Downside
Reiterated
04/10/24
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Pharma Mar SA

Which Analyst Should I Follow If I Want to Buy ES:PHM and Sell After:
1 Month
xxx
Success Rate
2/4 ratings generated profit
50%
Average Return
+3.08%
reiterated a xxx
rating 11 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +3.08% per trade.
3 Months
xxx
Success Rate
3/4 ratings generated profit
75%
Average Return
+10.60%
reiterated a xxx
rating 11 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +10.60% per trade.
1 Year
Ami FadiaNeedham
Success Rate
1/4 ratings generated profit
25%
Average Return
+26.63%
reiterated a buy rating 11 months ago
Copying Ami Fadia's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of +26.63% per trade.
2 Years
xxx
Success Rate
3/4 ratings generated profit
75%
Average Return
+64.63%
reiterated a xxx
rating 11 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of +64.63% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

PHM Analyst Recommendation Trends

Rating
Jan 23
Apr 23
Apr 24
Aug 24
Oct 24
Strong Buy
0
0
1
1
1
Buy
5
5
2
2
2
Hold
0
0
0
0
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
5
3
3
4
In the current month, PHM has received 3 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. PHM average Analyst price target in the past 3 months is €61.50.
Each month's total comprises the sum of three months' worth of ratings.

PHM Stock Forecast FAQ

What is ES:PHM’s average 12-month price target, according to analysts?
Based on analyst ratings, Pharma Mar SA’s 12-month average price target is €61.50.
    What is ES:PHM’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for ES:PHM, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Pharma Mar SA a Buy, Sell or Hold?
        Pharma Mar SA has a consensus rating of Moderate Buy, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
          What is Pharma Mar SA’s share price target?
          The average share price target for Pharma Mar SA is €61.50. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is €60.00 ,and the lowest forecast is €60.00. The average share price target represents -38.16% Decrease from the current price of €99.45.
            What do analysts say about Pharma Mar SA?
            Pharma Mar SA’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
              How can I buy shares of Pharma Mar SA?
              To buy shares of ES:PHM, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis